Related Experiment Videos
Transitional cell ovarian carcinoma in a BRCA1 mutation carrier
Gautam G Rao1, Raheela Ashfaq, John O Schorge
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Obstetrics and Gynecology
|April 27, 2002
Summary
Transitional cell ovarian carcinoma, a rare epithelial ovarian cancer subtype, has been identified in a patient with a BRCA1 mutation. This finding suggests a potential link between BRCA1 mutations and this specific ovarian cancer variant.
Area of Science:
- Oncology
- Genetics
- Gynecologic Pathology
Background:
- BRCA1 mutations significantly elevate the risk of epithelial ovarian cancer.
- The transitional cell variant of ovarian cancer is rare and its association with BRCA1 mutations is not well-established.
Observation:
- A perimenopausal woman presented with symptoms suggestive of advanced ovarian cancer.
- Surgical pathology confirmed stage IIIC transitional cell ovarian carcinoma.
- Genetic testing revealed a germline BRCA1 5382insC mutation in the patient.
Findings:
- This case represents the first reported instance of transitional cell ovarian carcinoma in a BRCA1 mutation carrier.
- The findings highlight a potential association between BRCA1 mutations and this rare ovarian cancer histology.
Implications:
- This case expands the understanding of BRCA-associated gynecologic malignancies.
- It may inform genetic counseling and screening protocols for BRCA1 mutation carriers.
- Further research is warranted to elucidate the biological mechanisms linking BRCA1 mutations to transitional cell ovarian carcinoma.